Fjarde Ap-fonden’s Healthcare Realty HR Stock Holding History

Fjarde Ap-fonden’s Portfolio HR Stock Details HR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-95,000	Closed	-$1.45M	–	556
2023 Q3	$1.45M	Sell	95,000 -6,400	-6%	-$114K	0.02%	511
2023 Q2	$1.91M	Buy	101,400 +44,300	+78%	+$855K	0.02%	494
2023 Q1	$1.1M	Sell	57,100 -48,000	-46%	-$967K	0.01%	500
2022 Q4	$2.03M	Buy	+105,100	New	+$2.06M	0.03%	464

Other funds holding HR

Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

AAMU

APG Asset Management US New York $13B AUM 5.3% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

RIM

Rush Island Management New York $1.49B AUM 4.65% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return

Fjarde Ap-fonden's HR Position: Q4 2023 in Review

Fjarde Ap-fonden sold out of Healthcare Realty (HR) in Q4 2023, closing a stake of 95,000 shares — an estimated $1.45M sold.

Fjarde Ap-fonden first reported a position in HR in Q4 2022 and held it in 4 quarters. The position peaked at $2.03M in Q4 2022. 411 funds tracked by Wall St. Rank hold HR as of Q4 2023.

Fjarde Ap-fonden reported no remaining Healthcare Realty position as of Q4 2023 after selling out during the quarter.
Fjarde Ap-fonden sold 95,000 Healthcare Realty shares in Q4 2023, an estimated $1.45M.
Fjarde Ap-fonden first reported a position in Healthcare Realty in Q4 2022 and held it in 4 quarters.
Fjarde Ap-fonden's Healthcare Realty position peaked at $2.03M in Q4 2022.
411 funds tracked by Wall St. Rank held Healthcare Realty as of Q4 2023.

Based on Fjarde Ap-fonden's 13F filing for Q4 2023, filed 14 Feb 2024.